The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (NASDAQ:PACB) Given New $7.00 Price Target at The Goldman Sachs Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Acquired by China Universal Asset Management Co. Ltd. themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clear Harbor Asset Management LLC Acquires 7,400 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price gapped up before the market opened on Monday . The stock had previously closed at $3.68, but opened at $3.81. Pacific Biosciences of California shares last traded at $3.69, with a volume of 590,328 shares traded. Analysts Set New Price Targets Several equities […]